In recent years, COVID-19 is an acute respiratory disease with high infectivity and strong pathogenicity. So far, the novel coronavirus has shown a high degree of variability. With the evolution of the Omicron virus strain, Asian data show that the interval of secondary infection in all countries is generally shortened. Early antiviral treatment can reduce the risk of death, hospitalization, and medical costs. In order to further explore new developments in the field and promote disciplinary development, the Chengdu High tech Medical Association successfully held the "Rheumatology and Immunology Series Conference and Respiratory Disease Infection Expert Exchange Conference" online on June 11, 2025. The conference invited renowned experts in the field of respiration to give special academic presentations, focusing on classic cases and cutting-edge technologies related to respiratory disease infections for academic discussions and exchanges. Representatives attending the conference expressed that they have benefited greatly.